anmelden
Novartis Aktie
128,84
EUR
+0,86
EUR
+0,67
%
129,04
EUR
+1,66
EUR
+1,30
%
Novartis jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Novartis Aktie Analyse
| 05.11.21 | Novartis Neutral | UBS AG | |
| 04.11.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 04.11.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 27.10.21 | Novartis Underweight | Barclays Capital | |
| 27.10.21 | Novartis Sell | Deutsche Bank AG | |
| 27.10.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 27.10.21 | Novartis Neutral | Credit Suisse Group | |
| 26.10.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
|
Werbung
|
|||
| 26.10.21 | Novartis Buy | UBS AG | |
| 26.10.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 26.10.21 | Novartis Sell | Deutsche Bank AG | |
| 25.10.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 25.10.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 25.10.21 | Novartis Buy | UBS AG | |
| 14.10.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 12.10.21 | Novartis Market-Perform | Bernstein Research | |
| 11.10.21 | Novartis Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 08.10.21 | Novartis Buy | UBS AG | |
| 07.10.21 | Novartis Buy | Jefferies & Company Inc. | |
| 05.10.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 20.09.21 | Novartis Sell | Deutsche Bank AG | |
| 17.09.21 | Novartis Hold | Deutsche Bank AG | |
| 14.09.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 13.09.21 | Novartis Hold | Deutsche Bank AG | |
| 06.09.21 | Novartis Hold | Kepler Cheuvreux | |
| 04.08.21 | Novartis Buy | UBS AG | |
| 28.07.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 27.07.21 | Novartis Overweight | Morgan Stanley | |
| 23.07.21 | Novartis Buy | UBS AG | |
| 22.07.21 | Novartis Hold | Deutsche Bank AG | |
| 22.07.21 | Novartis Neutral | Credit Suisse Group | |
| 22.07.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 21.07.21 | Novartis Market-Perform | Bernstein Research | |
| 21.07.21 | Novartis Market-Perform | Bernstein Research | |
| 21.07.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 21.07.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 21.07.21 | Novartis Buy | UBS AG | |
| 21.07.21 | Novartis Buy | Jefferies & Company Inc. | |
| 20.07.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 12.07.21 | Novartis Buy | Jefferies & Company Inc. | |
| 06.07.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 24.06.21 | Novartis Hold | Kepler Cheuvreux | |
| 17.06.21 | Novartis buy | Deutsche Bank AG | |
| 15.06.21 | Novartis buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 07.06.21 | Novartis Neutral | Credit Suisse Group | |
| 04.06.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 04.06.21 | Novartis buy | UBS AG | |
| 04.06.21 | Novartis buy | Jefferies & Company Inc. | |
| 21.05.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 19.05.21 | Novartis Underweight | JP Morgan Chase & Co. | |
Werbung
Werbung
